Novartis AG vs TotalEnergies SE — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while TotalEnergies SE trades at $83.46 (market cap $179.99B). The key difference: Novartis AG is the larger of the two by market cap, and TotalEnergies SE pays the higher dividend (5.22%). Which is the better fit depends on your goals.
| NVS | TTE | |
|---|---|---|
Market Cap | $290.25B | $179.99B |
Sector | Health | Energy |
52-Week High | $168.62 | $93.60 |
52-Week Low | $113.50 | $57.39 |
Enterprise Value | $330.27B | $214.14B |
Dividend Yield | 3.17% | 5.22% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →